Waldi

Pawel Trawkowski who is working at Gilead proposed as new member of Molecure SA supervisory board.Bio: molecure.com/app/uploads/2022/06/rb_2...Translation in attachm...

Very interesting presentation from Molecure: molecure.com/app/uploads/2022/06/mole...

Interesting info. New candidate for Molecule supervisory board is working at Gilead Sciences. Source: biznes.pap.pl/espi/pl/reports/view/at...,2022...

Drug-drug Interaction GLPG4716 and Nintedanib and Pirfenidone is completed. Now its Galapagos turn to push it to next phase.clinicaltrials.gov/ct2/show/NCT049717...

New website: molecure.com/en/...

Newest investor presentation from Molecure: oncoarendi.com/wp-content/uploads/202...

OAT name change is officially done. New WSE ticker name is MOC -> MOLECURE. Fun fact is that in polish MOC is in english POWER :)...

ryvu.com/2021/12/14/ryvu-announces-op...

New supervisory board members accepted by shareholders oncoarendi.com/en/oncoarendi-therapeu...

Maybe it will be interesting for someone... Onco Arendi is preparing to name change which will much better corresponding to the new strategy. New name will be Molecure S.A.Two new people in supervis...

Onco Arendi is preparing to name change which will much better corresponding to the new strategy. New name will be Molecure S.A.And two new people in supervisory board: Dr Nancy Van Osselaer and Dr ...

@gigatron: you made my day. great storytelling talent :))))) greets from Poland...

Looks that GLPG4716 and Midazolam drug-drug interaction study is completed. clinicaltrials.gov/ct2/show/NCT05030857Step by step we are closer to Phase II......

Here is new presentation from Oncoarendi (OAT). Published after latest quarterly financial meeting with investors (4.11.2021)PDF: oncoarendi.com/wp-content/uploads/2021/11/Investor_presentation_20...